Related Experiment Video
Updated: Dec 31, 2025

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
Published on: September 3, 2013
Genetic Encoding of Targeted Magnetic Resonance Imaging Contrast Agents for Tumor Imaging
Simone Schuerle1, Maiko Furubayashi2,3, Ava P Soleimany4,5,6
1Institute for Translational Medicine, Department of Health Sciences and Technology , ETH Zurich , CH-8092 Zurich , Switzerland.
Genetically engineered magnetic nanoparticles displaying targeting peptides show promise for cancer imaging. These novel magnetosomes enhance tumor targeting and MRI contrast, aiding in cancer diagnosis and treatment.
Failed At:
2026-06-19T13:47:47.317833+00:00
More Related Videos
11:27Preparation and In Vitro Characterization of Dendrimer-based Contrast Agents for Magnetic Resonance Imaging
Published on: December 4, 2016
13:21Preparation, Purification, and Characterization of Lanthanide Complexes for Use as Contrast Agents for Magnetic Resonance Imaging
Published on: July 21, 2011
Related Concept Videos
Magnetic Resonance Imaging
Imaging Studies I: CT and MRI
Description of the Procedures
Computed Tomography (CT) scan:
Computed Tomography (CT) scans use X-ray technology to generate detailed images of bones, organs, and tissues. During the scan, the patient lies on a moving table...